Families at risk of bowel cancer may be missing out on important testing, researchers from the University of Melbourne have found.
A new study of those at genetic risk of the cancer found that 50% of participants declined genetic testing when informed of the insurance implications.
“This indicates that people have a significant fear of insurance discrimination which impacts their decision to have potentially life saving genetic testing,” said co-lead author Dr Louise Keogh, of the University of Melbourne’s Key Centre for Women’s Health in Society.
The study is published in the Medical Journal of Australia.
Read more at The University of Melbourne